Promethazine and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Soliris (eculizumab). Common drug interactions include vitamin d deficiency among females and hypertensive encephalopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Promethazine and Soliris. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.



On Jul, 05, 2026

65 people who take Promethazine and Soliris together, and have interactions are studied.

Promethazine and Soliris drug interactions.

What are the common drug interactions of Promethazine and Soliris, by gender? *:

female:

  1. Vitamin d deficiency
  2. Blood disorder
  3. Infection
  4. Stress
  5. Dyspnoea (difficult or laboured respiration)
  6. Platelet count decreased
  7. Red blood cell count decreased
  8. Cough
  9. Infusion related reaction
  10. Urinary tract infection

male:

  1. Hypertensive encephalopathy (neurological dysfunction induced by malignant hypertension)
  2. Urticaria (rash of round, red welts on the skin that itch intensely)
  3. Bone marrow failure
  4. Cytomegalovirus gastritis (virus infection of stomach)
  5. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  6. Neoplasm malignant (cancer tumour)
  7. Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum)
  8. Venous thrombosis (blood clot (thrombus) that forms within a vein)

What are the common drug interactions of Promethazine and Soliris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Fatigue (feeling of tiredness)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Headache (pain in head)
  5. Oropharyngeal pain
  6. Stress
  7. Viral upper respiratory tract infection
  8. Vitamin b12 deficiency
  9. Vitamin d deficiency
  10. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

30-39:

  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Ear infection
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Kidney transplant rejection
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Oropharyngeal pain
  9. Pyrexia (fever)
  10. Renal transplant

40-49:

  1. Headache (pain in head)
  2. Axillary vein thrombosis (formation of a blood clot in axillary vein)
  3. Blood pressure increased
  4. Dyspnoea (difficult or laboured respiration)
  5. Hypervolaemia (abnormally increased volume of blood)

50-59:

  1. Platelet count decreased
  2. Red blood cell count decreased
  3. White blood cell count decreased
  4. Blood disorder
  5. Breast cancer
  6. Cervix carcinoma (cancer of cervix)
  7. Colon cancer metastatic (cancer of colon spreads to other part of body)
  8. Dehydration (dryness resulting from the removal of water)
  9. Depression
  10. Fatigue (feeling of tiredness)

60+:

  1. Abdominal discomfort
  2. Anaemia (lack of blood)
  3. Fatigue (feeling of tiredness)
  4. Infusion related reaction
  5. Logorrhoea (excessive, uncontrollable, or incoherent talkativeness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Oxygen consumption decreased
  8. Pneumonia
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 34 people, 52.31%
  2. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 17 people, 26.15%
  3. Pain: 10 people, 15.38%
  4. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 9 people, 13.85%
  5. Migraine (headache): 5 people, 7.69%
  6. Nausea And Vomiting: 4 people, 6.15%
  7. High Blood Pressure: 4 people, 6.15%
  8. Diabetes: 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Promethazine and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promethazine and Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and eculizumab (the active ingredients of Promethazine and Soliris, respectively), and Promethazine and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: